Topic: Value of Medical Writing

Podcasts

website thumbnail (1)
Episode 29: What's Hot & What's Not for Regulatory Medical Writing in 2025

The rapidly growing industry of regulatory medical writing calls for a 2025 prediction podcast! Listen up for “What’s Hot and What’s Not” from our experts Lisa Chamberlain James, Julia Forjanic Klapproth and Sonica Batra and get a glimpse of what Trilogy, an Indegene Company and Indegene will be up to this year.  

a graphic to lead them to the clinical overviews podcast on apple podcasts, google podcasts, or spotify

episode 28 thumbnail (1)
Episode 28: Exploring the Past, Present and Future of Orphan Drugs

Long time friends and industry colleagues, Lisa Chamberlain James with Trilogy and Cheryl Roberts with BioMarin Pharmaceutical sit down to discuss orphan drugs. They go over clinical trial hurdles, key incentives for health authorities, the medical writing process and start with an important question – why are orphan drugs called orphan drugs? Find out on episode 28 of TriloTalk!  

a graphic to lead them to the clinical overviews podcast on apple podcasts, google podcasts, or spotify

TriloTalk Episode 20 Website Thumbnail
Episode 20: Q&A With Trilotalk: Focus on General Medical Writing Principles 

In this episode, Julia and Lisa take a deep dive into General Medical Writing Principles. Join them as they navigate through a diverse range of topics that are crucial in the everyday practice of crafting clear and concise regulatory documents. Our hosts will generously share their personal insights, experiences, and invaluable tips that have positioned them as Masters in the field of medical writing. Happy podcasting! 

The Value of Medical Writing
Episode 3: The Value of Medical Writing

“Pay me now or pay me later”. TriloTalk episode 3 features Julia and Gretchen Griffin as they talk and discuss the value of medical writing and what a good medical writer brings to the table.

Publications

Clinical study protocol_Julia Forjanic Klapproth_Trilogy Writing
How well-written clinical study protocols get drugs to patients faster
In the world of drug development and approval, time is of the essence. But beginning the process with a poorly written protocol will only impede teams before a study has even begun. Julia Forjanic Klapproth, co-founder of Trilogy Writing & Consulting, describes how a well-written protocol will help patients receive their treatments sooner rather than later.
Author: Julia Forjanic Klapproth
Journal: Clinical Trials Insight
Date: July 2023
ICT Front Cover
Strategic Benefits
Julia Forjanic Klapproth of Trilogy Writing and Consulting elucidates how strategic medical writingcan help communicate key messages across development programmes and make sure teamsstay focused on a common goal. I...
Author: Julia Forjanic Klapproth
Journal: ICT Medical Writing
Date: Nov 2011
ICT-Magazine-The-Future-Awaits-Us-Article-May-2020
The Future Awaits Us
Off the back of the release of Trilogy Writing & Consulting’s second special edition magazine, EPC sits down with Barry Drees to expand on medical writing trends in the industry....
Author: Barry Drees
Journal: European Pharmaceutical Contractor, EPC
Date: May 2020
Cover-Pharma-Tech-Outlook
Quality-Driven Medical Writing
For years, the clinical drug development industry has been waging war against the surging drug development costs and tediously long processes. More efficient decision making during drug development would be...
Author: Stacey Smith
Journal: Pharma Tech Outlook, Clinical Trial Management Edition
Date: December 2019
01_Medical writing in the Old World_Barry Drees_the Write Stuff 8-3_1999_Thumbnail
Medical Writing in the Old World
Although there has been what amounts to medical writing here for a long time, it is a relatively new concept as a specialized profession.
Author: Barry Drees
Journal: The Write Stuff, The journal of EMWA
Date: Vol.8, No.3, 1999